Alexandre Becker/LinkedIn
May 15, 2026, 15:46
Alexandre Becker: Clinical Importance of Neonatal Thrombocytopenia in Newborns
Alexandre Becker, Professor of Postgraduate Studies in Clinical Hematology, Hemotherapy, and Quality Management and Control at ULBRA, shared a post on LinkedIn:
”Neonatal Thrombocytopenia
Neonatal thrombocytopenia is a common condition in neonatal intensive care units (15–40percent of infants), serving as a crucial marker of severe diseases such as sepsis, viral infection, necrotizing enterocolitis, or alloimmunization.
Its importance lies in the high risk of bleeding (including intracranial hemorrhage) and the need for rapid diagnosis to differentiate treatable causes and prevent serious sequelae or death.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight